{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T07:30:58.443069+00:00","company":{"ticker":"TGNT","cik":846377,"company_name":"Totaligent, Inc."},"pagination":{"limit":100,"returned":8,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"3f8c9ef8cffb18f871d31e60d2764cf65ff7fb66","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-04-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Definitive Agreement","agreement_type":"asset_purchase","counterparty":"Ivan Klarich","effective_date":"2026-04-10","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. entered into Definitive Agreement with Ivan Klarich (effective 2026-04-10).","evidence_excerpt":"On April 10, 2026, Totaligent, Inc. (the “Company”) entered into a Definitive Agreement (the “Definitive Agreement”) with Ivan Klarich (“Klarich”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002227","anchor_url":"https://secwatch.observer/filing/0001477932-26-002227#claim-3f8c9ef8cffb18f871d31e60d2764cf65ff7fb66","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226002227/0001477932-26-002227-index.htm"},{"fact_type":"material_agreement","fact_key":"9f866a0397a3317a2f0003c705868a332583d6ac","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-03-27T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Extension Amendment","agreement_type":"other","counterparty":"GloMed Solutions Limited Liability Company","effective_date":"2026-03-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. amended Extension Amendment with GloMed Solutions Limited Liability Company (effective 2026-03-22).","evidence_excerpt":"On March 22, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 22, 2026 (the “LOI”) with GloMed Solutions Limited Liability Company (“GloMed”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001611","anchor_url":"https://secwatch.observer/filing/0001477932-26-001611#claim-9f866a0397a3317a2f0003c705868a332583d6ac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001611/0001477932-26-001611-index.htm"},{"fact_type":"material_agreement","fact_key":"991989cd19d7422860f9be833875d5dcfd319014","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-03-24T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Extension Amendment","agreement_type":"other","counterparty":"Aetherium Medical","effective_date":"2026-03-04","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001548","anchor_url":"https://secwatch.observer/filing/0001477932-26-001548#claim-991989cd19d7422860f9be833875d5dcfd319014","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001548/0001477932-26-001548-index.htm"},{"fact_type":"material_agreement","fact_key":"1016c90da030dc1aeaa70b24ebf92d266214adf6","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-03-04T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Extension Amendment","agreement_type":"other","counterparty":"Aetherium Medical","effective_date":"2026-03-04","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001167","anchor_url":"https://secwatch.observer/filing/0001477932-26-001167#claim-1016c90da030dc1aeaa70b24ebf92d266214adf6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/0001477932-26-001167-index.htm"},{"fact_type":"material_agreement","fact_key":"8d73e1142c5246eff64184ef64124b60090a05ff","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-02-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Binding Letter of Intent","agreement_type":"other","counterparty":"GloMed Solutions Limited Liability Company","effective_date":"2026-02-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. entered into Binding Letter of Intent with GloMed Solutions Limited Liability Company (effective 2026-02-22).","evidence_excerpt":"On February 22, 2026, Totaligent, Inc. (the “Company”) entered into a Binding Letter of Intent (the “LOI”) with GloMed Solutions Limited Liability Company (“GloMed”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001016","anchor_url":"https://secwatch.observer/filing/0001477932-26-001016#claim-8d73e1142c5246eff64184ef64124b60090a05ff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001016/0001477932-26-001016-index.htm"},{"fact_type":"material_agreement","fact_key":"c6bebf7b99122f93a1b6922b14f9a1c034a1ab3c","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2026-02-12T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Binding Letter of Intent","agreement_type":"asset_purchase","counterparty":"Aetherium Medical","effective_date":"2026-02-11","item_codes_triggered":["1.01"],"value_text":null},"claim":"Totaligent, Inc. entered into Binding Letter of Intent with Aetherium Medical (effective 2026-02-11).","evidence_excerpt":"On February 11, 2026, Totaligent, Inc. (the “Company”) entered into a Binding Letter of Intent (the “LOI”) with Aetherium Medical (“Aetherium”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-000765","anchor_url":"https://secwatch.observer/filing/0001477932-26-000765#claim-c6bebf7b99122f93a1b6922b14f9a1c034a1ab3c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/0001477932-26-000765-index.htm"},{"fact_type":"executive_change","fact_key":"029188eaf3","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2025-04-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-04-18","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Ben Hansel resigned as director at Totaligent, Inc..","evidence_excerpt":"Effective April 18, 2025, Ben Hansel resigned as a director of Totaligent, Inc. (the “Company”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-25-002874","anchor_url":"https://secwatch.observer/filing/0001477932-25-002874#claim-029188eaf3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793225002874/0001477932-25-002874-index.htm"},{"fact_type":"executive_change","fact_key":"e340001511","cik":846377,"ticker":"TGNT","company_name":"Totaligent, Inc.","filed_at":"2025-04-21T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-18","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Brian Heckathorne was elected as director at Totaligent, Inc..","evidence_excerpt":"Effective April 18, 2025, the Board of Directors of the Company elected Brian Heckathorne to serve as a director.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-25-002874","anchor_url":"https://secwatch.observer/filing/0001477932-25-002874#claim-e340001511","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793225002874/0001477932-25-002874-index.htm"}]}